Literature DB >> 16080118

Mitochondrial DNA polymerase W748S mutation: a common cause of autosomal recessive ataxia with ancient European origin.

Anna H Hakonen1, Silja Heiskanen, Vesa Juvonen, Ilse Lappalainen, Petri T Luoma, Maria Rantamaki, Gert Van Goethem, Ann Lofgren, Peter Hackman, Anders Paetau, Seppo Kaakkola, Kari Majamaa, Teppo Varilo, Bjarne Udd, Helena Kaariainen, Laurence A Bindoff, Anu Suomalainen.   

Abstract

Mutations in the catalytic subunit of the mitochondrial DNA polymerase gamma (POLG) have been found to be an important cause of neurological disease. Recently, we and collaborators reported a new neurodegenerative disorder with autosomal recessive ataxia in four patients homozygous for two amino acid changes in POLG: W748S in cis with E1143G. Here, we studied the frequency of this allele and found it to be among the most common genetic causes of inherited ataxia in Finland. We identified 27 patients with mitochondrial recessive ataxia syndrome (MIRAS) from 15 Finnish families, with a carrier frequency in the general population of 1 : 125. Since the mutation pair W748S+E1143G has also been described in European patients, we examined the haplotypes of 13 non-Finnish, European patients with the W748S mutation. Haplotype analysis revealed that all the chromosomes carrying these two changes, in patients from Finland, Norway, the United Kingdom, and Belgium, originate from a common ancient founder. In Finland and Norway, long, common, northern haplotypes, outside the core haplotype, could be identified. Despite having identical homozygous mutations, the Finnish patients with this adult- or juvenile-onset disease had surprisingly heterogeneous phenotypes, albeit with a characteristic set of features, including ataxia, peripheral neuropathy, dysarthria, mild cognitive impairment, involuntary movements, psychiatric symptoms, and epileptic seizures. The high carrier frequency in Finland, the high number of patients in Norway, and the ancient European founder chromosome indicate that this newly identified ataxia should be considered in the first-line differential diagnosis of progressive ataxia syndromes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16080118      PMCID: PMC1226208          DOI: 10.1086/444548

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  29 in total

1.  Quantitative analysis of human DNA sequences by PCR and solid-phase minisequencing.

Authors:  A Suomalainen; A C Syvänen
Journal:  Mol Biotechnol       Date:  2000-06       Impact factor: 2.695

2.  Deletion of the yeast homologue of the human gene associated with Friedreich's ataxia elicits iron accumulation in mitochondria.

Authors:  F Foury; O Cazzalini
Journal:  FEBS Lett       Date:  1997-07-14       Impact factor: 4.124

3.  Mutation of POLG is associated with progressive external ophthalmoplegia characterized by mtDNA deletions.

Authors:  G Van Goethem; B Dermaut; A Löfgren; J J Martin; C Van Broeckhoven
Journal:  Nat Genet       Date:  2001-07       Impact factor: 38.330

4.  Identification of 5'-deoxyribose phosphate lyase activity in human DNA polymerase gamma and its role in mitochondrial base excision repair in vitro.

Authors:  M J Longley; R Prasad; D K Srivastava; S H Wilson; W C Copeland
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

5.  A primer-guided nucleotide incorporation assay in the genotyping of apolipoprotein E.

Authors:  A C Syvänen; K Aalto-Setälä; L Harju; K Kontula; H Söderlund
Journal:  Genomics       Date:  1990-12       Impact factor: 5.736

6.  Functional defects due to spacer-region mutations of human mitochondrial DNA polymerase in a family with an ataxia-myopathy syndrome.

Authors:  Petri T Luoma; Ningguang Luo; Wolfgang N Löscher; Carol L Farr; Rita Horvath; Julia Wanschitz; Stefan Kiechl; Laurie S Kaguni; Anu Suomalainen
Journal:  Hum Mol Genet       Date:  2005-05-25       Impact factor: 6.150

7.  The occurrence of dominant spinocerebellar ataxias among 251 Finnish ataxia patients and the role of predisposing large normal alleles in a genetically isolated population.

Authors:  V Juvonen; M Hietala; V Kairisto; M-L Savontaus
Journal:  Acta Neurol Scand       Date:  2005-03       Impact factor: 3.209

8.  Clinical and genetic abnormalities in patients with Friedreich's ataxia.

Authors:  A Dürr; M Cossee; Y Agid; V Campuzano; C Mignard; C Penet; J L Mandel; A Brice; M Koenig
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

9.  Infantile onset spinocerebellar ataxia with sensory neuropathy: a new inherited disease.

Authors:  T Koskinen; P Santavuori; K Sainio; M Lappi; A K Kallio; H Pihko
Journal:  J Neurol Sci       Date:  1994-01       Impact factor: 3.181

10.  Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion.

Authors:  V Campuzano; L Montermini; M D Moltò; L Pianese; M Cossée; F Cavalcanti; E Monros; F Rodius; F Duclos; A Monticelli; F Zara; J Cañizares; H Koutnikova; S I Bidichandani; C Gellera; A Brice; P Trouillas; G De Michele; A Filla; R De Frutos; F Palau; P I Patel; S Di Donato; J L Mandel; S Cocozza; M Koenig; M Pandolfo
Journal:  Science       Date:  1996-03-08       Impact factor: 47.728

View more
  86 in total

Review 1.  Mitochondrial DNA replication and disease: insights from DNA polymerase γ mutations.

Authors:  Jeffrey D Stumpf; William C Copeland
Journal:  Cell Mol Life Sci       Date:  2010-10-08       Impact factor: 9.261

Review 2.  [Clinical details and genetics of recessive ataxias].

Authors:  C Zühlke; F Kreuz; K Bürk
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

3.  Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphismin mitochondrial disorders.

Authors:  Sherine S L Chan; Matthew J Longley; William C Copeland
Journal:  Hum Mol Genet       Date:  2006-11-06       Impact factor: 6.150

4.  Screening for POLG1 mutations in a Southern Italian ataxia population.

Authors:  C Criscuolo; P Mancini; S Ammendola; D Cicala; S Banfi; G De Michele; A Filla
Journal:  J Neurol       Date:  2007-12-19       Impact factor: 4.849

Review 5.  Inherited mitochondrial diseases of DNA replication.

Authors:  William C Copeland
Journal:  Annu Rev Med       Date:  2008       Impact factor: 13.739

Review 6.  Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options.

Authors:  Ayman W El-Hattab; Fernando Scaglia
Journal:  Neurotherapeutics       Date:  2013-04       Impact factor: 7.620

7.  Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing.

Authors:  Hai-Lin Dong; Yin Ma; Quan-Fu Li; Yi-Chu Du; Lu Yang; Sheng Chen; Zhi-Ying Wu
Journal:  CNS Neurosci Ther       Date:  2018-05-13       Impact factor: 5.243

Review 8.  The mitochondrial DNA polymerase in health and disease.

Authors:  William C Copeland
Journal:  Subcell Biochem       Date:  2010

Review 9.  Mouse models of mitochondrial DNA defects and their relevance for human disease.

Authors:  Henna Tyynismaa; Anu Suomalainen
Journal:  EMBO Rep       Date:  2009-01-16       Impact factor: 8.807

Review 10.  A mechanistic view of human mitochondrial DNA polymerase gamma: providing insight into drug toxicity and mitochondrial disease.

Authors:  Christopher M Bailey; Karen S Anderson
Journal:  Biochim Biophys Acta       Date:  2010-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.